Vista Medical Stock Will Continue to Be Listed on Nasdaq SmallCap Market Via an Exception CARLSBAD, Calif., May 11 /PRNewswire-FirstCall/ -- Vista Medical Technologies, Inc., , today announced that it has received the determination of the Nasdaq Listing Qualifications Panel that its common stock will continue to be listed on the Nasdaq SmallCap Market via an exception to the Shareholders' Equity Requirement. The Company had requested this exception at a hearing of the Panel on April 1, 2004. While Vista Medical has failed to meet the Shareholders' Equity requirement since September 30, 2003, the Panel has granted the Company a temporary exception from this standard, subject to meeting certain conditions. The exception will expire on June 1, 2004. In the event that the Company is deemed to have met the terms of the exception, it shall continue to be listed on the Nasdaq SmallCap Market. The Company believes it can meet these conditions; however, there can be no assurance that it will do so. If, at some future date, the Company's securities should cease to be listed on The Nasdaq SmallCap Market, they may continue to be listed in the OTC Bulletin Board. For the duration of this exception, the Company's Nasdaq symbol will be VMTIC. Vista Medical Technologies, Inc. Our business is focused exclusively on the disease state management of morbid obesity, through our wholly-owned subsidiary, VOW Solutions, Inc. We provide program management, operational consulting and clinical training services to physicians and hospitals involved in the medical and surgical treatment of morbidly obese patients. We also provide specialized vitamins to patients who have undergone obesity surgery. Our corporate website is http://www.vistamt.com/; our obesity disease state management website is http://www.vowsolutionsinc.com/; information on our nutritional supplements for post-surgical gastric bypass patients may be found on http://www.vistavitamins.com/. Vista Medical Technologies is traded on the Nasdaq SmallCap Market under the stock symbol VMTIC. Forward Looking Statements This news release may contain forward-looking statements concerning the business and products of Vista Medical. Actual results may differ materially depending on a number of risk factors, including, but not limited to the following: the Company's efforts to attain the continued listing requirement for Shareholders' Equity on the Nasdaq stock exchange; the success of the Company's appeal to the Nasdaq Listing Qualifications Panel; the Company's ability to raise additional capital to fund our operations and execute our business plan; the Company's ability to penetrate the market for obesity surgery management services; customer acceptance of our products and services. Other risks inherent in our business are described in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended December 31, 2003 and our most recent quarterly report on form 10-Q. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this release. For further information, please contact John R. Lyon, President of Vista Medical Technologies, +1-760-603-9120, ; or investor and media, Tony Rossi of Financial Relations Board, +1-310-407-6563, , for Vista Medical Technologies. DATASOURCE: Vista Medical Technologies CONTACT: John R. Lyon, President of Vista Medical Technologies, +1-760-603-9120, ; or investor and media, Tony Rossi of Financial Relations Board, +1-310-407-6563, , for Vista Medical Technologies Web site: http://www.vistavitamins.com/ Web site: http://www.vowsolutionsinc.com/ Web site: http://www.vistamt.com/ Company News On-Call: http://www.prnewswire.com/comp/127279.html

Copyright